• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective.消费者可接受的风险:烟草公司如何回应其产品存在缺陷的指控。
Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv84-9. doi: 10.1136/tc.2004.009837.
2
Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.烟草制造商针对原告提出的癌症因果关系索赔的抗辩:往墙上扔泥巴,希望能沾上一些。
Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv17-26. doi: 10.1136/tc.2006.016956.
3
Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.有缺陷过滤嘴的香烟销售了40年:菲利普·莫里斯公司从未告知吸烟者的事。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I51-61. doi: 10.1136/tc.11.suppl_1.i51.
4
Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.烟草行业的虚假承诺及其对消费者关于吸烟健康风险的错误认知的影响。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I110-7. doi: 10.1136/tc.11.suppl_1.i110.
5
No sisyphean task: how the FDA can regulate electronic cigarettes.并非徒劳无功的任务:美国食品药品监督管理局如何监管电子烟
Yale J Health Policy Law Ethics. 2013 Summer;13(2):326-74.
6
Tobacco companies protest about federal court ruling on corrective statements.烟草公司对联邦法院关于纠正声明的裁决提出抗议。
BMJ. 2014 Oct 6;349:g6067. doi: 10.1136/bmj.g6067.
7
Tobacco industry consumer research on socially acceptable cigarettes.烟草行业关于社会可接受香烟的消费者研究。
Tob Control. 2005 Oct;14(5):e3. doi: 10.1136/tc.2005.011239.
8
Receipt and redemption of cigarette coupons, perceptions of cigarette companies and smoking cessation.烟券的收取与兑换、对烟草公司的看法与戒烟。
Tob Control. 2013 Nov;22(6):418-22. doi: 10.1136/tobaccocontrol-2012-050539. Epub 2012 Oct 9.
9
The cigarette controversy.香烟争议
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1070-6. doi: 10.1158/1055-9965.EPI-06-0912.
10
Snuffing out cigarette sales and the smoking deaths epidemic.杜绝香烟销售与吸烟致死的流行趋势。
N Z Med J. 2007 Jun 15;120(1256):U2587.

引用本文的文献

1
The past is not the future in tobacco control.在烟草控制领域,过去的情况并不代表未来。
Prev Med. 2020 Nov;140:106183. doi: 10.1016/j.ypmed.2020.106183. Epub 2020 Jun 27.
2
Assumption of Risk and the Role of Health Warnings Labels in the United States.风险自负原则与美国健康警示标签的作用。
Nicotine Tob Res. 2020 May 26;22(6):975-983. doi: 10.1093/ntr/ntz089.
3
Transnational Tobacco Companies and New Nicotine Delivery Systems.跨国烟草公司与新型尼古丁输送系统
Am J Public Health. 2019 Feb;109(2):227-235. doi: 10.2105/AJPH.2018.304813. Epub 2018 Dec 20.
4
Cigarettes become a dangerous product: tobacco in the rearview mirror, 1952-1965.香烟成为危险产品:1952-1965 年的烟草业。
Am J Public Health. 2014 Jan;104(1):37-46. doi: 10.2105/AJPH.2013.301475. Epub 2013 Nov 14.
5
Tobacco and the invention of quitting: a history of gender, excess and will-power.烟草与戒烟的发明:一部关于性别、过度和意志力的历史。
Sociol Health Illn. 2013 Jun;35(5):778-92. doi: 10.1111/j.1467-9566.2012.01529.x. Epub 2013 Apr 21.
6
Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.基于香烟过滤嘴的检测方法作为毒物暴露和吸烟行为的替代指标——文献综述。
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3321-33. doi: 10.1158/1055-9965.EPI-09-0925.
7
The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food?忽视历史的危害:大烟草公司行为不端,数百万人丧生。食品巨头与之有多大相似之处呢?
Milbank Q. 2009 Mar;87(1):259-94. doi: 10.1111/j.1468-0009.2009.00555.x.
8
Maximum yields might improve public health--if filter vents were banned: a lesson from the history of vented filters.如果禁止使用过滤通风口,最大产量可能会改善公众健康:来自通风过滤器历史的教训。
Tob Control. 2006 Jun;15(3):262-6. doi: 10.1136/tc.2006.016501.

本文引用的文献

1
Are smokers adequately informed about the health risks of smoking and medicinal nicotine?吸烟者是否充分了解吸烟和药用尼古丁对健康的风险?
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S333-40. doi: 10.1080/14622200412331320734.
2
Ammonia and other chemical base tobacco additives and cigarette nicotine delivery: issues and research needs.氨及其他化学碱性烟草添加剂与香烟尼古丁释放量:问题与研究需求
Nicotine Tob Res. 2004 Apr;6(2):199-205. doi: 10.1080/1462220042000202472.
3
Percent free base nicotine in the tobacco smoke particulate matter of selected commercial and reference cigarettes.所选商业香烟和参比香烟的烟草烟雾颗粒物中游离碱尼古丁的百分比。
Chem Res Toxicol. 2003 Aug;16(8):1014-8. doi: 10.1021/tx0340596.
4
Does menthol enhance the addictiveness of cigarettes? An agenda for research.薄荷醇会增强香烟的成瘾性吗?一项研究议程。
Nicotine Tob Res. 2003 Feb;5(1):9-11. doi: 10.1080/1462220031000070543.
5
Why tobacco litigation?为何进行烟草诉讼?
Tob Control. 2003 Mar;12(1):1-2. doi: 10.1136/tc.12.1.1.
6
Harm reduction: 25 years later.减少伤害:25年后。
Tob Control. 2002 Dec;11(4):287-8. doi: 10.1136/tc.11.4.287.
7
Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.烟草行业的虚假承诺及其对消费者关于吸烟健康风险的错误认知的影响。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I110-7. doi: 10.1136/tc.11.suppl_1.i110.
8
Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.有缺陷过滤嘴的香烟销售了40年:菲利普·莫里斯公司从未告知吸烟者的事。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I51-61. doi: 10.1136/tc.11.suppl_1.i51.
9
Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents.香烟过滤嘴通风是一种有缺陷的设计,因为它会带来误导性的口感、更大的烟雾量以及堵塞的通风口。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I40-50. doi: 10.1136/tc.11.suppl_1.i40.
10
The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact.营销看似“淡味”香烟的阴暗面:成功的形象与失败的事实。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I18-31. doi: 10.1136/tc.11.suppl_1.i18.

消费者可接受的风险:烟草公司如何回应其产品存在缺陷的指控。

Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective.

作者信息

Cummings K Michael, Brown Anthony, Douglas Clifford E

机构信息

Department of Health Behavior, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

出版信息

Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv84-9. doi: 10.1136/tc.2004.009837.

DOI:10.1136/tc.2004.009837
PMID:17130628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2563578/
Abstract

OBJECTIVE

To describe arguments used by cigarette companies to defend themselves against charges that their cigarettes were defective and that they could and should have done more to make cigarettes less hazardous.

METHODS

The data for this paper come from the opening statements made by defendants in four court cases: two class action lawsuits (Engle 1999, and Blankenship 2001) and two individual cases (Boeken 2001, and Schwarz 2002). The transcripts of opening statements were reviewed and statements about product defect claims, product testing, and safe cigarette research were excerpted and coded.

RESULTS

Responses by cigarette companies to charges that their products were defective has been presented consistently across different cases and by different companies. Essentially the arguments made by cigarette companies boil down to three claims: (1) smoking is risky, but nothing the companies have done has made cigarettes more dangerous than might otherwise be the case; (2) nothing the companies have done or said has kept someone from stopping smoking; and (3) the companies have spent lots of money to make the safest cigarette acceptable to the smoker.

CONCLUSIONS

Cigarette companies have argued that their products are inherently dangerous but not defective, and that they have worked hard to make their products safer by lowering the tar and nicotine content of cigarettes as recommended by members of the public health community. As a counter argument, plaintiff attorneys should focus on how cigarette design changes have actually made smoking more acceptable to smokers, thereby discouraging smoking cessation.

摘要

目的

描述烟草公司用于为自己辩护的论点,以回应关于其香烟存在缺陷以及他们本可以且应该采取更多措施降低香烟危害的指控。

方法

本文的数据来自四起法庭案件中被告的开场陈述:两起集体诉讼(恩格尔案,1999年;布兰肯希普案,2001年)和两起个人案件(博肯案,2001年;施瓦茨案,2002年)。对开场陈述的文字记录进行了审查,并摘录和编码了有关产品缺陷索赔、产品测试和安全香烟研究的陈述。

结果

烟草公司对其产品存在缺陷指控的回应在不同案件和不同公司中表现一致。本质上,烟草公司提出的论点归结为三点:(1)吸烟有风险,但公司所做的任何事情都没有使香烟比原本更危险;(2)公司所做或所说的任何事情都没有阻止某人戒烟;(3)公司已花费大量资金使最安全的香烟为吸烟者所接受。

结论

烟草公司辩称其产品本质上是危险的但无缺陷,并且他们已努力按照公共卫生界人士的建议降低香烟的焦油和尼古丁含量,以使产品更安全。作为反驳论点,原告律师应关注香烟设计的改变实际上如何使吸烟对吸烟者更具吸引力,从而阻碍戒烟。